Change of Peripheral Blood Mononuclear Cells IFN-γ, IL-10, and TGF-β1 mRNA Expression Levels With Active Human Cytomegalovirus Infection in Orthotopic Liver Transplantation

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1767-1769

  Zhang, Y ^a   Wang, Y L ^a,b   Liu, Y W ^d   Li, Q ^a   Yuan, Y H ^c   Niu, W Y ^a   Sun, L Y ^b   Zhu, Z J ^b   Shen, Z Y ^b   Han, R F ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

^c Tianjin Blood Center   (China)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 10; MESSENGER RNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE EXPRESSION; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ADULT; CYTOMEGALOVIRUS INFECTIONS; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67249129241     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.064     Document Type: Article

References (16)

1. Falagas M.E., Snydman D.R., Griffith J., et al. Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. Clin Infect Dis 23 (1996) 468
2. George M.J., Snydman D.R., Werner B.G., et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 103 (1997) 106
3. Nichols W.G., Corey L., Gooley T., et al. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 185 (2002) 273
4. Sagedal S., Nordal K.P., Hartmann A., et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2 (2002) 850
5. Burak K.W., Kremers W.K., Batts K.P., et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 8 (2002) 362
6. Mocarski Jr. E.S. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10 (2002) 332
7. Szabo S.J., Sullivan B.M., Peng S.L., et al. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21 (2003) 713
8. Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237
9. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415
10. Samuel C.E. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183 (1991) 1
11. Wang Y.L., Zhang Y.Y., Zhou Y.L., et al. T Helper and T Cytotoxic cells subsets monitoring during active cytomegalovirus infection in liver transplantation. Transplantation Proc 36 (2004) 1498
12. Donnelly R.P., Dickensheets H., and Finbloom D.S. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine 19 (1999) 563
13. Nordoy I., Muller F., Nordal K.P., et al. The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J Infect Dis 181 (2000) 51
14. Reinke P., Fietze E., Ode-Hakim S., et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 344 (1994) 1737
15. Kowdley K.V., Fawaz K.A., and Kaplan M.M. Extrahepatic biliary stricture associated with cytomegalovirus in a liver transplant recipient. Transpl Int 9 (1996) 161
16. Wang Y., Liu Y., Zhang Y., et al. The role of the CD95, CD38 and TGFbeta1 during active human cytomegalovirus infection in liver transplantation. Cytokine 35 (2006) 193